Abstract:The conventional CRISPR-mediated detection technologies typically involve two separate steps: target preamplification and CRISPR-mediated signal detection. This multi-step procedure is not only cumbersome but also prone to cross-contamination. Here, we propose a new CRISPR-mediated nucleic acid detection methodology, termed CRISPR-one (CRISPR-mediated testing in one-tube, one-pot). At a constant temperature, CRISPRone carries out both multiple cross displacement amplification (MCDA) for target pre-amplification and CRISPR/ AapCas12b-based cleavage for signal detection in a single reaction pot. The novel CRISPR-one technique is employed for detecting Mycoplasma pneumoniae (M. pneumoniae), a causative agent for community-acquired pneumonia in children. M. pneumoniae CRISPR-one targets the CARDS (community-acquired respiratory distress syndrome toxin) gene and performs at 60 degrees C for 50 min with only basic instrumentation required. The results can be easily visualized through a real-time fluorescence instrument, with the entire process taking less than an hour. The lowest detection limit of M. pneumoniae CRISPR-one was 50 fg (similar to 55 copies) of genomic DNA per reaction, and no cross-reactivity with non-M. pneumoniae templates was observed. In clinical applications, the CRISPR-one assay demonstrated a high level of agreement with both the microfluidic chip method (Kappa value: 0.95) and real-time PCR (Kappa value: 0.93) when analyzing 135 oropharynx swab samples. There is no statistical difference in detection efficiency between our assay and other methods. Together, the CRISPR-one developed here offers a rapid, convenient, highly sensitive, and specific approach for pathogen detection (e.g., M. pneumoniae), serving as an invaluable tool for clinical diagnosis and epidemiologic surveillance, particularly in resource-limited laboratories.

Cas14a1-mediated nucleic acid detectifon platform for pathogens

A One-Pot, One-Step CRISPR Platform (Crispr-One) for Nucleic Acid Detection: Application for the Detection of Mycoplasma Pneumoniae

A field-deployable method for single and multiplex detection of DNA or RNA from pathogens using Cas12 and Cas13

End-point Dual Specific Detection of Nucleic Acids Using CRISPR/Cas12a Based Portable Biosensor.

DropCRISPR: A LAMP-Cas12a Based Digital Method for Ultrasensitive Detection of Nucleic Acid.

A Programmable Sensitive Platform for Pathogen Detection Based on CRISPR/Cas12a -Hybridization Chain Reaction-Poly T-Cu

Ultrasensitive detection of Salmonella typhi using a PAM-free Cas14a-based biosensor

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

Cas14a1-advanced LAMP for ultrasensitive and visual Pathogen diagnostic

A Sensitive Nucleic Acid Detection Platform for Foodborne Pathogens Based on CRISPR-Cas13a System Combined with Polymerase Chain Reaction

Combining tag-specific primer extension and magneto-DNA system for Cas14a-based universal bacterial diagnostic platform

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Universal CRISPR/Cas12a-associated aptasensor suitable for rapid detection of small proteins with a plate reader

Development of an inducible Cas9 nickase and PAM-free Cas12a platform for bacterial diagnostics

Biosensing bacterial 16S rDNA by microchip electrophoresis combined with a CRISPR system based on real-time crRNA/Cas12a formation

CRISPR-Cas12a-based nanoparticle biosensor for detection of pathogenic bacteria in food

Application of CRISPR/Cas12a in the rapid detection of pathogens

Sensitive detection of a bacterial pathogen using allosteric probe-initiated catalysis and CRISPR-Cas13a amplification reaction

CRISPR-Cas13a based bacterial detection platform: Sensing pathogen Staphylococcus aureus in food samples

Aptamer-based Cas14a1 biosensor for amplification-free live pathogenic detection